Daclatasvir is indicated: In combination with sofosbuvir, with or without ribavirin, for the treatment of chronic hepatitis C virus (HCV) infection genotype 1 or 3 in adults.
In combination with pegIFN/RBV for the treatment of chronic hepatitis C virus (HCV) infection genotype 4 in adults.
Other Services
Country
Account